Cyril Amarchand Mangaldas Advises Adani Enterprises on ₹24,930 Crores Rights Issue
The transaction was undertaken in compliance with SEBI ICDR Regulations and marks one of the largest rights issues in the Indian capital markets.
CAM
Cyril Amarchand Mangaldas is acting as Indian legal counsel to PTC Inc. on the sale of its Kepware and ThingWorx businesses
The transaction involves multidisciplinary legal advice spanning M&A, employment, tax, data privacy, and equity compensation matters.
Cyril Amarchand Mangaldas Advises Zenrock Chemicals and EAAA India Alternatives on Indo Borax Acquisition and Open Offer
The transaction resulted in a change of control and triggered a mandatory open offer under SEBI takeover regulations, alongside structured acquisition financing.
Cyril Amarchand Mangaldas Advises IFC on Nephrocare Health Services Limited IPO
The IPO comprised a fresh issue and an offer for sale, with IFC divesting part of its shareholding. Nephrocare’s equity shares were listed on Indian stock exchanges on 17 December 2025.
CAM Represents KKR in Investment in Lighthouse Learning
The investment, announced on November 25, was made by funds managed by KKR along with participation from new investor PSP Investments of Canada, reinforcing confidence in India’s education sector.
Cyril Amarchand Mangaldas represented Lighthouse Learning Private Limited and Mr. Prajodh Rajan (Founder and Group CEO) of Lighthouse Learning Private Limited.
The transaction strengthens Lighthouse Learning’s position as a leading Indian education services provider. CAM advised on corporate, diligence, real estate, employment, disputes, finance, and competition aspects of the deal.
Cyril Amarchand Mangaldas advises Larsen & Toubro Limited
The transaction marks the first phase of consolidating L&T’s real estate assets into a unified entity positioned for India’s growing property market.
Cyril Amarchand Mangaldas advises Serum Institute on sale of stake held in Biocon Biologics and subscription of shares in Biocon Limited, through share swap
Cyril Amarchand Mangaldas advised Serum Institute on the proposed sale of its stake in Biocon Biologics to Biocon and the simultaneous subscription of shares in Biocon Limited through a share swap transaction valued at ₹2,250 crore. The deal marks a significant restructuring in India’s biopharmaceutical sector.
Cyril Amarchand Mangaldas advised Ashoka Buildcon Limited on Macquarie’s exit from its group entities, Ashoka Concessions Limited and Jaora – Nayagaon Toll Road Company Private Limited
CAM advised Ashoka Buildcon Limited on Macquarie’s ~₹1,715 crore exit from its group entities, providing end-to-end transactional support on the divestment of stakes in Ashoka Concessions Limited and Jaora—Nayagaon Toll Road Company Private Limited.
Cyril Amarchand Mangaldas successfully represented Coinswitch in a domain name dispute concerning an impugned domain before the WIPO UDRP Panel
The Panel upheld Coinswitch’s claim on all three UDRP criteria, finding confusing similarity, lack of legitimate rights, and bad faith registration and use.
Cyril Amarchand Mangaldas advises TPG on its multi-billion dollar joint venture with Tata Consultancy Services Limited, HyperVault
The deal involves an initial USD 2 billion equity commitment, with an additional USD 4—5 billion planned through debt, marking one of India’s largest private equity investments in the digital infrastructure sector.
CAM Advises Fisdom and its Promoters on 100% Acquisition by Groww
The firm advised on transactional, regulatory, and data-privacy aspects, with the deal signed on 16 May 2025 and completed on 6 October 2025. Fisdom provides mutual fund, stockbroking, PMS, and tax-filing services.
CAM advised the book running lead managers on the IPO of Physicswallah Limited
The firm’s Capital Markets and sectoral experts guided the BRLMs, Kotak, J.P. Morgan, Goldman Sachs and Axis Capital, through the transaction, which opened on 11 November 2025.
Cyril Amarchand Mangaldas advised the book running lead managers on the IPO of Billionbrains Garage Ventures Limited (‘Groww’)
Cyril Amarchand Mangaldas advised the book running lead managers on the ₹66,230 million IPO of Billionbrains Garage Ventures Limited (Groww), which saw strong investor demand with an overall subscription of 17.60 times.
Cyril Amarchand Mangaldas advises Lenskart on ₹73 Billion IPO
Cyril Amarchand Mangaldas advised Lenskart Solutions Limited and its promoters on the company’s ₹72,780 million IPO comprising a fresh issue and offer for sale, marking one of the most significant public offerings in the Indian retail tech sector.
CAM advises Megha Engineering & Infrastructures Ltd. and its subsidiary MEIL Energy on acquisition of 100% shares of TAQA Neyveli Power Company
Cyril Amarchand Mangaldas advised Megha Engineering & Infrastructures Limited and its subsidiary MEIL Energy Private Limited on acquisition of 100% shares of TAQA Neyveli Power Company Limited
Cyril Amarchand Mangaldas Advises ReNew Pvt. Ltd. on ₹1,700 Crore Sale of 300 MW Solar Power Asset in Rajasthan to Sembcorp Green Infra
Cyril Amarchand Mangaldas acted as legal counsel for ReNew Private Limited on the sale of 100% of its wholly owned subsidiary, ReNew Sun Bright Private Limited
CAM advises the underwriters on LG Electronics India Limited’s IPO, the highest subscribed ‘large’ IPO in India
The Company is a leading electronics manufacturing company with products such as washing machines, refrigerators, panel televisions, inverter air conditioners, and microwaves.
CAM advises Everest Reinsurance Company on Establishment of IFSC Insurance Office in GIFT City
Everest Reinsurance Company, IFSC Branch received the IFSCA Certificate of Registration for undertaking reinsurance business in IFSC as an IFSC Insurance Office at the GIFT City, Gujarat, India, on September 19, 2025.
CAM advises Cactus Partners Fund I on its follow-on investment in Intangles Lab Pvt. Ltd.
CAM had also advised Cactus Partners Fund I on its first Intangles Lab Private Limited participating in the Pre-Series B funding with Baring Private Equity India.